Versant Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Versant Capital Management's NEO Position: Q2 2026 in Review
Versant Capital Management held its NeoGenomics (NEO) position steady in Q2 2026 at 1,708 shares worth $24.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.
Versant Capital Management first reported a position in NEO in Q1 2022 and has held it in 18 quarters since. The position peaked at $30.1K in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Versant Capital Management held 1,708 shares of NeoGenomics worth $24.9K as of Q2 2026.
- Versant Capital Management left its NeoGenomics share count unchanged in Q2 2026.
- NeoGenomics made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1825 holding.
- Versant Capital Management first reported a position in NeoGenomics in Q1 2022 and has held it in 18 quarters since.
- Versant Capital Management's NeoGenomics position peaked at $30.1K in Q1 2023.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.